Hints and tips:
Related Special Reports
...If patients live longer, “it’s good for business”, says David Altshuler, Vertex’s chief scientific officer....
...A 2022 consumer survey carried out by the Boston Consulting Group found that 75 per cent of 3,700 respondents in seven countries said having a healthier diet was the main motivator for them to start eating...
...Boston Scientific and Edwards Lifesciences, both of which have large cardiovascular businesses, command an average multiple of around 22....
...The UK government is promoting the golden triangle — Cambridge, Oxford and London — as a global centre for life sciences investment to compete with Boston and San Francisco....
...To develop a successful cluster like greater Boston or San Diego takes about 25 years, according to Marcus....
...But Aduhelm’s approval has provoked a wave of controversy, with some scientists arguing there is scant scientific evidence that it actually works....
...the audience on Tuesday in Boston....
...Common Asset Management, Boston, MA, US Waive drug firm IP rules before the next pandemic / From Nick Dearden, Global Justice Now, London SW9, UK...
...Frederic Tudor of Boston made his fortune transporting ice blocks carved from frozen New England lakes to the US south and beyond, paving the way for ice-cooled ships and rail cars....
...David Mitchell, founder of Patients for Affordable Drugs, a US campaign group, said that for some companies, such as Boston-based biotech Moderna, the government seemed to be paying for everything....
...“I was disappointed that the prevention for a deadly disease was discussed in political terms rather than scientific facts,” Mr Bourla wrote....
...While many well-known healthcare companies scored highly on BoA’s ESG metrics (Johnson & Johnson, UnitedHealth and Boston Scientific to name a few), one company was a notable laggard: Moderna....
...It has taken just 10 months, in UK prime minister Boris Johnson’s flamboyant assessment, for “the scientific cavalry” to arrive....
...Other contenders in the race to develop the first Covid-19 vaccine include GlaxoSmithKline, Sanofi, Pfizer and Boston-based biotech Moderna....
...Private equity firm Livingbridge has appointed three new associate directors: Isabelle Hemington in London, Tom Reece in Manchester and Taha Bakhtiyar in Boston....
...scientific puts snake venom unit up for sale (BBG)...
...The race for a vaccine appeared to be picking up pace this week when Moderna, a Boston-based biotech company, unveiled early positive results for its potential vaccine in a small trial — and AstraZeneca...
...Editas Medicine, a Boston-based biotech, will seek to restore patients’ sight using Crispr-Cas9 technology in a person, in vivo, not a Petri dish....
...Our team interviewed Burlakoff last summer, before he was sentenced, under the supervision of the prosecutors at a studio in Boston....
...The Boston-based biotech has become the first company to use Crispr in a clinical trial, to treat patients with blood disorder beta thalassaemia, which affects the movement of oxygen around the body and...
...Vor was co-founded with PureTech Health, a Boston-based, London-listed biopharma company working on novel medicines for the brain, immune system and gut. PureTech now owns about 30 per cent of Vor....
...Splitting his time between London and Boston, Mr Tobin is head of global for SPDR, State Street’s ETF business....
...One thing to start: Bankers are sometimes accused of being snake oil salesmen . . . but in the case of the £3.3bn takeover of UK healthcare group BTG by Boston Scientific on Tuesday, they kind of just lived...
...The writer is author of ‘How Emotions Are Made: The Secret Life of the Brain’ and professor of psychology at Northeastern University, Boston...
...Given that there is no shortage of scientific talent — or money — in New York, why has it taken so long for a biotech industry to emerge in the city?...
International Edition